Stigmatizing language on websites delays care for liver disease patients
The vast majority of liver transplant centers in the United States use language on their websites that can be considered...
care
Shaping the Future of Kidney Care
Fresenius Medical Care delivers on commitments during a year of fundamental transformation Progress towards sustainability goals in key areas: patient...
Fresenius Medical Care launches “Augmented Reality” for training on Kidney Replacement Therapy device
Press release For the first time, Fresenius Medical Care develops and utilizes “Augmented Reality” (AR) to train medical staff in...
Fresenius Medical Care launches “Augmented Reality” for training on Kidney Replacement Therapy device
For the first time, Fresenius Medical Care develops and utilizes "Augmented Reality" (AR) to train medical staff in Intensive Care...
Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies
Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System. This...
Blood clots following hospital care
Prevention of blood clots, medically known as venous thromboembolism (VTE), is a key patient safety priority for hospitals. VTE includes...
